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ABSTRACT
Despite its importance, underreporting of the active content of
experimental and comparator interventions in published literature has
not been previously examined for behavioural trials. We assessed
completeness and variability in reporting in 142 randomised controlled
trials of behavioural interventions for smoking cessation published
between 1/1996 and 11/2015. Two coders reliably identiﬁed the
potential active components of experimental and comparator
interventions (activities targeting behaviours key to smoking cessation
and qualifying as behaviour change techniques, BCTs) in published, and
in unpublished materials obtained from study authors directly.
Unpublished materials were obtained for 129/204 (63%) experimental
and 93/142 (65%) comparator groups. For those, only 35% (1200/3403)
of experimental and 26% (491/1891) of comparator BCTs could be
identiﬁed in published materials. Reporting quality (#published BCTs/
#total BCTs) varied considerably between trials and between groups
within trials. Experimental (vs. comparator) interventions were better
reported (B(SE) = 0.34 (0.11), p < .001). Unpublished materials were more
often obtained for recent studies (B(SE) = 0.093 (0.03), p = .003) published
in behavioural (vs. medical) journals (B(SE) = 1.03 (0.41), p = .012). This
high variability in underreporting of active content compromises
reader’s ability to interpret the eﬀects of individual trials, compare and
explain intervention eﬀects in evidence syntheses, and estimate the
additional beneﬁt of an experimental intervention in other settings.
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Background
Identifying eﬀective intervention strategies for modifying health behaviours and behaviours of
healthcare professionals is critical to improving population health and reducing healthcare
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expenditure (Jepson, Harris, Platt, & Tannahill, 2010; NICE, 2007; WHO, 2013). Accurate and
comprehensive reporting of such interventions allows readers to understand exactly what has
been developed and evaluated, what resources are required to deliver it, and what is needed for repli-
cation of the intervention and its implementation in other settings. Full intervention descriptions are
also key to evidence syntheses and economic modelling of interventions to inform policy and
practice.
Behavioural interventions are often experimentally evaluated against active comparator
groups to investigate eﬀectiveness; for example, behavioural support for smoking cessation,
treatment-as-usual, or the same intervention delivered through diﬀerent means (e.g., group
vs. individual). These comparators may – like experimental interventions – include a range of
active intervention ingredients, which is thought to inﬂuence success rates in the comparator
arm and therefore trial eﬀect sizes (de Bruin et al., 2010; de Bruin, Viechtbauer, Hospers,
Schaalma, & Kok, 2009; Wagner & Kanouse, 2003). Hence, current guidance for reporting of
trials and their interventions recommends that both experimental and comparator interventions
are reported in similar detail (e.g., Albrecht, Archibald, Arseneau, & Scott, 2013; Hoﬀmann, Glas-
ziou, et al., 2014; Montgomery et al., 2018).
Previous studies examining behavioural and complex interventions found incomplete report-
ing of intervention characteristics to be common (Candy, Vickerstaﬀ, Jones, & King, 2018;
Hoﬀmann, Erueti, & Glasziou, 2013; Lohse, Pathania, Wegman, Boyd, & Lang, 2018). Several
studies suggest that comparator interventions may be more poorly reported than experimental
interventions (Byrd-Bredbenner et al., 2017; de Bruin et al., 2009; de Bruin et al., 2010; Lohse
et al., 2018). Comprehensive reporting of behavioural interventions includes, amongst others,
how (e.g., in-person or via a mobile phone app), where (e.g., at home or in a community
centre), by whom (e.g., a nurse or pharmacist), and how often (e.g., a single 10-minute consultation
or ten 1-hour sessions over a 6-month period) the intervention was delivered (Hoﬀmann, Glasziou,
et al., 2014; Kok et al., 2016; Montgomery et al., 2018). These characteristics are relatively easy to
report, and for readers and systematic reviewers to identify as ‘missing’ when not reported. Except
for Hoﬀman and colleagues (2013), these reporting studies used only the primary trial papers to
examine the reporting of intervention characteristics and did not include study protocols, study
websites, and supplemental materials.
The active content of behavioural interventions (what was done to induce change) is consider-
ably more challenging to report, and to identify as missing when not reported, than the how,
where, or whom of intervention delivery. Yet, understanding the active content of experimental
and comparator interventions is important for interpreting eﬀects of individual trials, for explain-
ing heterogeneity in treatment eﬀects in evidence syntheses, and for estimating the likely eﬀec-
tiveness of an intervention in another setting. Several reporting studies provide indirect evidence
that active content of descriptions of interventions may be particularly poor, as they found that
intervention materials were rarely provided in publications (e.g., Abell, Glasziou, & Hoﬀmann,
2015; Albarqouni, Glasziou, & Hoﬀmann, 2018; Bryant, Passey, Hall, & Sanson-Fisher, 2014;
Hoﬀmann et al., 2013; Sakzewski, Reedman, & Hoﬀmann, 2016). Only one study provides direct evi-
dence of underreporting of active content in behavioural trials: Lorencatto and colleagues (2012)
compared published intervention descriptions with intervention descriptions in full intervention
manuals obtained from study authors of smoking cessation trials. They found that on average
44.4% of potential active content that could be identiﬁed in manuals could also be identiﬁed in
the trial paper. Limitations of this study were the low author response rate to requests for inter-
vention manuals (28/152, 18.4%), that it only examined experimental interventions, and – like
other reporting studies – used the primary trial paper only to identify published intervention
content. Hence, despite a growing literature suggesting that underreporting of study character-
istics in non-pharmacological or complex interventions is common, there is no robust evidence
on the degree and variability in underreporting of active content in experimental and comparator
interventions in behavioural trials.
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Deﬁning the potential active content of behavioural interventions
We consider the ‘active content’ of behavioural interventions to be comprised of those intervention
activities (done to and/or by the intervention recipient) that target behaviours relevant to the
outcome of interest, and that qualify as a behaviour change technique (BCT) according to the 93-
item BCT Taxonomy v1 (BCTTv1) (Michie et al., 2013). For example, in order to motivate smokers
to quit smoking a pharmacist may ‘provide smokers with information about the health beneﬁts of
smoking cessation, namely… ..’. This intervention activity targets the behaviour ‘quitting smoking’
and qualiﬁes as BCT ‘5.1 Providing information about health consequences’. Additionally, following
an initial quit attempt, an intervention may include planning and problem solving exercises, which
targets the behaviour ‘abstinence’ and qualify as the BCTs ‘1.1 Goal setting’ and ‘1.2 Problem
solving’. For the remainder of the paper we refer to these intervention activities as ‘active content’,
but it should be noted that the evidence base regarding the eﬀectiveness of BCTs and their appli-
cation in speciﬁc contexts is still in development. Hence, this content is presumed to be active.
In simple interventions, as few as one or two BCTs may be identiﬁed, but usually behavioural inter-
ventions are more complex and can include 20 or more BCTs (Bartlett, Sheeran, & Hawley, 2014; Gli-
dewell et al., 2018). Even routine treatment-as-usual conversations between health care professionals
and patients can contain 15 or more BCTs (de Bruin et al., 2009; de Bruin, Dima, Texier, & van Ganse,
2018; Lorencatto et al., 2012; Oberjé, Dima, Pijnappel, Prins, & de Bruin, 2015). This makes accurate
reporting of the active content of behavioural interventions particularly challenging. Additionally,
it can be hard for readers to identify the extent to which the active content has been comprehen-
sively reported in trial reports.
Study aim and research questions
The literature on intervention reporting raises some important concerns about the interpretation of
trial reports. For example, do published materials reliably allow readers to assess an intervention’s
active content and understand what an experimental intervention was adding – in terms of active
content – to the comparator group in a particular trial? Can systematic reviewers reliably use pub-
lished intervention descriptions to examine whether diﬀerences in eﬀect sizes between trials can
be accounted for by diﬀerences in interventions’ active content?
This study aimed to determine the degree towhich published (i.e., either publicly accessible or avail-
able behind a journal paywall) descriptions of interventions in experimental and comparator groups
accurately reﬂect the full active content of these interventions. This required comparing the active
content identiﬁed in published materials with the active content identiﬁed in comprehensive descrip-
tions of experimental and comparator interventions obtained from authors of a representative set of
trials. The current study was conducted as part of a larger systematic review project of smoking cessa-
tion interventions, employing novel methods for synthesising eﬀects of behavioural interventions
([NAME], PROSPERO [NUMBER]). The database includes a large number of trials published during a
period of 20 years and a range of diﬀerent types of experimental and comparator interventions.
This study was guided by three main research questions:
(1) What proportion of the active content of experimental and comparator interventions is described
in published materials?
(2) Does underreporting of the active content of experimental and comparator interventions in pub-
lished materials vary between trials?
(3) Does underreporting of the active content of interventions in published materials vary between
experimental and comparator groups within the same trial?
Whereas research question 1 relates simply to the amount of underreporting of active content,
research questions 2 and 3 concern whether or not the published information on the active
HEALTH PSYCHOLOGY REVIEW 3
content of interventions can be reliably used to compare diﬀerent trials, and diﬀerent interven-
tions (i.e., experimental vs comparator) within a trial. Additionally, this study examined which
trial characteristics are associated with the quality of active content reporting, and with author
responses to our requests for additional materials describing their experimental and comparator
interventions.
Methods
We searched the Cochrane Tobacco Addiction Group Specialised Register for randomised controlled
trials (RCTs) of behavioural interventions (with or without pharmacological support) to support
smoking cessation (search date: ﬁrst of November 2015). Trials were included if they had at least
six months follow-up and biochemically veriﬁed smoking cessation. We excluded trials published
before 1996, that were not reported in English or in peer-reviewed journals, or that recruited partici-
pants younger than 18 years. Detailed methods of the search strategy are published elsewhere
(de Bruin et al., 2016).
Materials and procedures
We ﬁrst obtained published materials from all of the 142 RCTs included in the [NAME] project, includ-
ing any articles (e.g., trial, protocol, or intervention development papers), their supplementary ﬁles, or
materials deposited elsewhere (e.g., repositories or study websites). Next, we attempted to contact
study authors from all included trials as follows. First authors were contacted by email (including
two reminders); if no response was received we called them by telephone; and if unsuccessful the
second and last authors were contacted by email, followed by the middle authors. This process
took about eight months, with one delayed response coming in at eleven months.
Authors were asked to send additional materials describing in detail the interventions delivered to
the experimental and comparator groups in their trial. Additional materials could be anything from
leaﬂets and website materials, to detailed intervention manuals. Two researchers (NJ and AJW) com-
pleted the online BCT training and practiced BCT coding on 25 trials not included in this systematic
review, prior to initiating the formal BCT coding. Both researchers – blinded to the propose of this
study – independently used the v1 taxonomy of BCTs (BCTTv1; Michie et al., 2013, 2015) to reliably
identify intervention components that targeted any of four key behaviours of interest (i.e., the initial
quit attempt, abstinence following a successful quit attempt, adherence to smoking cessation medi-
cation, and engagement with the intervention) and that qualiﬁed as BCTs (overall Prevalence and Bias
Adjusted Kappa (PABAK) = .98, agreed absent = 96.7% (124.417), agreed present = 2.6% (3306), dis-
agree = 0.8% (989)) (Black et al., 2018; de Bruin et al., 2016). The researchers ﬁrst examined the pub-
lished intervention materials and then identiﬁed the active content described in the additional
materials that the authors had sent. The BCTTv1 taxonomy was used as this is the most widely-
used instrument for describing and coding interventions in systematic reviews.
For comparator groups, especially those receiving treatment-as-usual, authors often do not have
(detailed) intervention materials. In order to address this information gap, we adopted a previously
validated method for collecting detailed descriptions of comparator interventions (de Bruin et al.,
2009, 2010). For that, we ﬁrst extracted from smoking cessation guidelines and related literature
(Fiore et al., 2008; HSE Tobacco Control Framework Implementation group, 2013; McEwen, 2014;
Michie et al., 2013; Michie, Hyder, Walia, & West, 2011; NHS Scotland, 2017), the potential active
content (i.e., practical intervention activities that target smoking cessation and qualify as a BCT) of
comprehensive treatment-as-usual smoking cessation programmes. We discussed this list with our
advisory board comprised of smoking cessation professionals and policy makers, and generated a
ﬁnal list of 60 practical intervention activities that qualiﬁed as potential active content. These practical
activities were included as items in a ‘comparator intervention checklist’, which was sent to authors,
asking them to report which of these had been delivered to the majority of participants in the
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comparator arm of their trial. Because all authors received the same checklist, a syntax was used to
link author responses to BCTs and hence these were not part of the intercoder reliability calculations
reported above. Also in this study, the checklist demonstrated high internal consistency reliability
(Cronbach’s alpha = .92) and predictive validity (see pre-print on https://osf.io/uvepa/).
In sum, the published materials as well as unpublished materials (manuals, websites, checklists)
were all sources of information on what practical intervention activities had been delivered to exper-
imental and comparator groups. From these materials we extracted the active content through iden-
tifying which of these activities targeted smoking cessation behaviours (quitting, abstaining,
medication adherence, treatment engagement) and that qualiﬁed as a BCT using the BCTTv1. An
elaboration on these methods is included in Appendix 1.
Finally, independent double coding (NJ, AJW, and NB) was conducted to evaluate the degree to
which the published and unpublished materials combined, provided a clear and comprehensive
description of the active content of each of the experimental and comparator interventions (report-
ing quality: 3 = well-described, 2 =moderately described, 1 = poorly described, 0 = not described;
PABAK = .79). Disagreements were resolved through discussion.
The local ethics committee (Institute of Applied Health Science, University of Aberdeen) judged
that ethics was not required for collecting data from study authors as this did not involve collecting
personal information.
Analyses
In the absence of evidence on the relative eﬀectiveness of the 93 BCTs in the BCTTv1 taxonomy in the
context of smoking cessation interventions (i.e., some may be more eﬀective than others), for simpli-
city we assumed that all intervention activities that qualify as active content are equally eﬀective (de
Bruin et al., 2009, 2010). Hence, the active content score of the experimental and comparator inter-
ventions in our analyses is reﬂected by the total number of BCTs that targeted any of the four beha-
viours considered to be of interest. When authors indicated in the manuscript or checklist that
intervention groups received the experimental intervention as an addition to the comparator inter-
vention (and not instead of), their active content score also included the comparator group checklist
data (76/204 [37%] of intervention groups).
Descriptive statistics were used to examine the total number of BCTs identiﬁed in the published
materials, and the additional number of BCTs identiﬁed in the unpublished materials obtained from
study authors (RQ1). Graphs and correlational analyses were used to examine variability in under-
reporting of the number of BCTs between experimental and comparator groups from diﬀerent
trials, as well as between groups from the same trial (RQ2). These analyses were restricted to
the experimental and comparator groups for which additional materials were obtained from
study authors.
Binomial mixed-eﬀects logistic regression was used to analyse factors that explained the quality of
reporting of experimental and comparator interventions. The dependent variable was the logit trans-
formed proportion of BCTs reported in published materials, out of the total number of BCTs ident-
iﬁed. Predictors were (a) time (coded as ‘publication year – 1996’), (b) journal impact factor (coded
as ‘log(impact factor)’), (c) behavioural versus medical journals (coded 1/0, respectively), (d) trial
sample size (coded as ‘log(trial sample size)’), (e) experimental versus comparator groups (coded
1/0, respectively), and (f) primary mode of delivery: person-delivered versus written interventions
(i.e., digital or print interventions; coded 1/0, respectively). All predictors were entered into the
model jointly. The model included random eﬀects for trials (to account for the multilevel structure
of the data, with groups nested within trials) and individual groups within trials (to account for poten-
tial overdispersion in the logit transformed proportions). For the dependent variable to be meaning-
ful, the analysis was restricted to the groups coded as well-described.
Logistic regression analyses using generalised estimating equations (GEE) were conducted to
identify whether groups for which additional unpublished materials could be retrieved were
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diﬀerent from those for which no unpublished materials were retrieved (i.e., missing data analyses),
using publication year, journal impact factor, journal type, trial sample size, group and primary mode
of intervention delivery as predictors (all variables were coded as described above). Trials were used
as the clustering variable and an exchangeable correlation structure was assumed. Our a-priori pub-
lished analysis plan, including hypotheses regarding the direction of eﬀects of these predictors, can
be found on the Open Science Framework (https://osf.io/23hfv/).
Results
From the 142 randomised controlled trials included in the review, additional unpublished materials
(including checklists) were retrieved for 129/204 (63%) experimental and 93/142 (65%; 69% if 8
passive comparator groups are removed) comparator groups. For experimental interventions,
authors sent a range of materials, such as the intervention manuals, trial protocols, and self-help
materials. For the comparator groups, 80/93 (86%) completed checklists were obtained and for 53/
93 (57%) existing documents describing the comparator intervention were sent, such as manuals
and self-help materials.
Table 1 shows the quality judgements for active content reporting for the experimental and
comparator interventions for which no additional materials were obtained versus those for which
additional materials were obtained. Overall, the active content of 144/204 (71%) of the experimental
and 110/142 (77%) of the comparator interventions were judged to be well-described. The quality
of descriptions was rated signiﬁcantly higher for groups for which additional materials were
obtained than for groups for which no additional materials were obtained (Mann–Whitney U =
6655, p < .001). Of the 29 experimental interventions rated as well-described based on the pub-
lished materials alone, 23 had detailed descriptions in the primary trial paper and in six cases
the intervention manuals were publicly available. Of the 21 well-described comparator groups
based on the published materials alone, 11 were attention or wait list controls, 6 adequately
described the content in the primary article, 2 reported using a publicly available standardised
method (i.e., 5As method) (Fiore, 2000; Fiore et al., 2008), and 2 reported using a publicly available
leaﬂet or website.
Proportion of active content identiﬁable in published materials
For the 222 experimental and comparator groups for which authors sent additional materials, 3403
BCTs were identiﬁed for the experimental interventions (Mdn = 25, IQR = 18, range 2–62 BCTs) and
1891 for the comparator interventions (Mdn = 19, IQR = 28, range 0–51 BCTs). Of these, only 35%
(1200/3403) of the BCTs in the experimental interventions and 26% (491/1891) of those in the
Table 1. Coder judgements on how well the active content of smoking cessation interventions was described for treatment arms
for which no additional intervention materials were obtained from trial authors, and those for which trial authors did sent
additional intervention materials.
Experimental Comparator
No material retrieved Material retrieved No material retrieved Material retrieved
Well-described 29
(39%)
115
(89%)
21
(43%)
89
(96%)
Moderately described 19
(25%)
8
(6%)
7
(15%)
0
(0%)
Poorly described 22
(29%)
6
(5%)
17
(36%)
0
(0%)
Not described 5
(7%)
0
(0%)
4
(8%)
4
(4%)a
Total 75
(100%)
129
(100%)
49
(100%)
93
(100%)
aFor four control groups additional materials were received but these did not include any useable information.
6 M. DE BRUIN ET AL.
comparator interventions could be identiﬁed in published materials. BCTs targeting initiating a quit
attempt appeared to be best reported, followed by BCTs targeting smoking abstinence, medication
adherence, and least well reported were those supporting intervention engagement (see Figure 1).
Table 2 shows the reporting quality at the level of individual BCTs (across the four behaviours),
for the experimental and comparator groups separately; and across treatment arms. BCTs are
ordered from best to worst reported, based on the total scores across treatment arms. The
quality of reporting of diﬀerent BCTs was very similar between experimental and comparator
arms, with a correlation of r = .64 (p < . 01) if all BCTs identiﬁed at least once in each treatment
arm were considered; r = 0.81 (p < .01) if only BCTs were considered that were reported at least
5 times in each arm; and r = .90 (p < .01) if only BCTs were considered that were reported at
least 10 times in each arm.
(a)
(b)
Figure 1. Percentage of total (bars) and mean (numbers) number of BCTs coded from published and the additional BCTs coded
from unpublished available materials, by behavioural target (Q = quitting; A = abstinence; MA =medication adherence; TE = treat-
ment engagement) and group (a. experimental; b. comparator).
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Table 2. Reporting quality of each behaviour change technique for experimental and comparator groups separately, and across
treatment arms (total). Behaviour change techniques are sorted from highest to lowest reporting quality across treatment arms.
Experimental Comparator Total
BCT % Published % Published % Published
1.7 Review outcome goal(s) 3/3
(100.00%)
– 3/3
(100.00%)
7.4 Remove access to the reward 2/2
(100.00%)
– 2/2
(100.00%)
10.7 Self-incentive 2/2
(100.00%)
3/3
(100.00%)
5/5
(100.00%)
10.8 Incentive (outcome) 4/4
(100.00%)
– 4/4
(100.00%)
14.2 Punishment 1/1
(100.00%)
– 1/1
(100.00%)
14.3 Remove reward 6/6
(100.00%)
– 6/6
(100.00%)
14.5 Rewarding completion 2/2
(100.00%)
– 2/2
(100.00%)
14.6 Situation-speciﬁc reward 1/1
(100.00%)
– 1/1
(100.00%)
14.10 Remove punishment 1/1
(100.00%)
– 1/1
(100.00%)
16.2 Imaginary reward 1/1
(100.00%)
– 1/1
(100.00%)
10.10 Reward (outcome) 17/18
(94.44%)
0/1
(0.00%)
17/19
(89.47%)
16.3 Vicarious consequences 5/6
(83.33%)
– 5/6
(83.33%)
2.5 Monitoring of outcome(s) of behaviour without feedback 4/6
(66.67%)
4/4
(100.00%)
8/10
(80.00%)
2.7 Feedback on outcome(s) of behaviour 23/30
(76.67%)
7/8
(87.50%)
30/38
(78.95%)
9.1 Credible source 36/49
(73.47%)
18/23
(78.26%)
54/72
(75.00%)
10.3 Non-speciﬁc reward 9/13
(69.23%)
3/4
(75.00%)
12/17
(70.59%)
3.1 Social support (unspeciﬁed) 147/191
(76.96%)
71/129
(55.04%)
218/320
(68.13%)
14.9 Self-reward 5/6
(83.33%)
1/3
(33.33%)
6/9
(66.67%)
6.1 Demonstration of the behaviour 9/12
(75.00%)
2/5
(40.00%)
11/17
(64.71%)
2.4 Self-monitoring of outcome(s) of behaviour 8/11
(72.73%)
0/2
(0.00%)
8/13
(61.54%)
1.5 Review behaviour goal(s) 8/14
(57.14%)
4/6
(66.67%)
12/20
(60.00%)
7.3 Reduce prompts/cues 22/38
(57.89%)
8/16
(50.00%)
30/54
(55.56%)
11.1 Pharmacological support 107/175
(61.14%)
50/111
(45.05%)
157/286
(54.90%)
2.1 Monitoring of behaviour by others without feedback 9/13
(69.23%)
1/6
(16.67%)
10/19
(52.63%)
1.8 Behavioural contract 6/11
(54.55%)
2/5
(40.00%)
8/16
(50.00%)
1.3 Goal setting (outcome) 5/10
(50.00%)
– 5/10
(50.00%)
9.3 Comparative imagining of future outcomes 2/4
(50.00%)
– 2/4
(50.00%)
12.6 Body changes 1/2
(50.00%)
– 1/2
(50.00%)
8.3 Habit formation 3/7
(42.86%)
3/5
(60.00%)
6/12
(50.00%)
1.1 Goal setting (behaviour) 74/134
(55.22%)
33/88
(37.50%)
107/222
(48.20%)
3.2 Social support (practical)
(Continued )
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Table 2. Continued.
Experimental Comparator Total
BCT % Published % Published % Published
9/20
(45.00%)
5/10
(50.00%)
14/30
(46.67%)
4.5 Tell to act 41/83
(49.40%)
29/71
(40.85%)
70/154
(45.45%)
14.1 Behaviour cost 4/7
(57.14%)
0/2
(0.00%)
4/9
(44.44%)
4.2 Information about antecedents 20/46
(43.48%)
9/20
(45.00%)
29/66
(43.94%)
6.2 Social comparison 24/57
(42.11%)
9/20
(45.00%)
33/77
(42.86%)
12.5 Adding objects to the environment 13/32
(40.63%)
4/8
(50.00%)
17/40
(42.50%)
3.3 Social support (emotional) 2/6
(33.33%)
2/4
(50.00%)
4/10
(40.00%)
6.3 Information about others’ approval 5/16
(31.25%)
4/7
(57.14%)
9/23
(39.13%)
5.3 Information about social and environmental consequences 47/115
(40.87%)
21/61
(34.43%)
68/176
(38.64%)
1.2 Problem solving 66/152
(43.42%)
25/95
(26.32%)
91/247
(36.84%)
13.1 Identiﬁcation of self as role model 10/34
(29.41%)
6/12
(50.00%)
16/46
(34.78%)
5.1 Information about health consequences 52/139
(37.41%)
22/77
(28.57%)
74/216
(34.26%)
11.4 Paradoxical instructions 2/4
(50.00%)
0/2
(0.00%)
2/6
(33.33%)
2.3 Self-monitoring of behaviour 19/65
(29.23%)
7/19
(36.84%)
26/84
(30.95%)
1.9 Commitment 21/66
(31.82%)
6/26
(23.08%)
27/92
(29.35%)
9.2 Pros and cons 29/79
(36.71%)
5/38
(13.16%)
34/117
(29.06%)
12.3 Avoidance/reducing exposure to cues for the behaviour 32/114
(28.07%)
17/55
(30.91%)
49/169
(28.99%)
4.1 Instruction on how to perform the behaviour 79/248
(31.85%)
30/143
(20.98%)
109/391
(27.88%)
2.2 Feedback on behaviour 15/49
(30.61%)
0/8
(0.00%)
15/57
(26.32%)
11.2 Reduce negative emotions 36/111
(32.43%)
7/59
(11.86%)
43/170
(25.29%)
8.6 Generalisation of target behaviour 10/42
(23.81%)
5/26
(19.23%)
15/68
(22.06%)
13.2 Framing/reframing 13/63
(20.63%)
8/38
(21.05%)
21
(20.79%)
8.1 Behavioural practice/rehearsal 11/42
(26.19%)
2/22
(9.09%)
13/64
(20.31%)
15.2 Mental rehearsal of successful performance 1/5
(20.00%)
– 1/5
(20.00%)
12.2 Restructuring the social environment 18/93
(19.35%)
9/47
(19.15%)
27/140
(19.29%)
13.5 Identity associated with changed behaviour 7/37
(18.92%)
4/24
(16.67%)
11/61
(18.03%)
1.4 Action planning 15/78
(19.23%)
8/62
(12.90%)
23/140
(16.43%)
1.6 Discrepancy between current behaviour and goal 6/37
(16.22%)
3/20
(15.00%)
9/57
(15.79%)
8.2 Behaviour substitution 13/80
(16.25%)
7/48
(14.58%)
20/128
(15.63%)
7.1 Prompts/cues 4/35
(11.43%)
3/15
(20.00%)
7/50
(14.00%)
5.5 Anticipated regret 2/8
(25.00%)
0/8
(0.00%)
2/16
(12.50%)
(Continued )
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Variability in active content reporting between trials
To examine whether published intervention descriptions would still allow for the comparison of the
interventions’ active content despite the above-illustrated underreporting, we examined the degree
to which reporting quality varied between trials.
Table 2. Continued.
Experimental Comparator Total
BCT % Published % Published % Published
5.6 Information about emotional consequences 8/64
(12.50%)
4/40
(10.00%)
12/104
(11.54%)
12.4 Distraction 9/66
(13.64%)
3/43
(6.98%)
12/109
(11.01%)
10.1 Material incentive (behaviour) 1/6
(16.67%)
0/4
(0.00%)
1/10
(10.00%)
10.9 Self-reward 4/64
(6.25%)
7/46
(15.22%)
11/110
(10.00%)
10.4 Social reward 9/81
(11.11%)
3/40
(7.50%)
12/121
(9.92%)
12.1 Restructuring the physical environment 10/103
(9.71%)
5/50
(10.00%)
15/153
(9.80%)
15.3 Focus on past success 3/46
(6.52%)
2/38
(5.26%)
5/84
(5.95%)
15.4 Self-talk 3/31
(9.68%)
0/22
(0.00%)
3/53
(5.66%)
5.2 Salience of consequences 3/46
(6.52%)
0/31
(0.00%)
3/77
(3.90%)
15.1 Verbal persuasion about capability 1/53
(1.89%)
0/34
(0.00%)
1/87
(1.15%)
2.6 Biofeedback 0/30
(0.00%)
0/25
(0.00%)
0/55
(0.00%)
4.4 Behavioural experiments 0/1
(0.00%)
– 0/1
(0.00%)
5.4 Monitoring of emotional consequences 0/6
(0.00%)
– 0/6
(0.00%)
7.5 Remove aversive stimulus 0/1
(0.00%)
0/2
(0.00%)
0/3
(0.00%)
7.6 Satiation 0/1
(0.00%)
– 0/1
(0.00%)
7.8 Associative learning 0/1
(0.00%)
– 0/1
(0.00%)
8.4 Habit reversal 0/7
(0.00%)
0/1
(0.00%)
0/8
(0.00%)
8.7 Graded tasks/BS9 set graded tasks 0/2
(0.00%)
– 0/2
(0.00%)
10.2 Material reward (behaviour) 0/19
(0.00%)
0/17
(0.00%)
0/36
(0.00%)
11.3 Conserving mental resources 0/33
(0.00%)
0/31
(0.00%)
0/64
(0.00%)
14.4 Reward approximation 0/6
(0.00%)
0/1
(0.00%)
0/7
(0.00%)
4.3 Re-attribution – – –
7.2 Cue signalling reward – – –
7.7 Exposure – – –
10.5 Social incentive – – –
10.6 Non-speciﬁc incentive – – –
10.11 Future punishment – – –
13.3 Incompatible beliefs – – –
13.4 Valued self-identify – – –
14.7 Reward incompatible behaviour – – –
14.8 Reward alternative behaviour – – –
16.1 Imaginary punishment – – –
Total 1200/3403
(35.26%)
491/1891
(25.97%)
1691/5294
(31.94%)
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Figure 2(a and b) show the experimental and comparator groups respectively (x-axis), ordered by
number of BCTs identiﬁed in published materials (white bars), after which the number of additional
BCTs identiﬁed in the unpublished materials were added (grey bars). While the published number
and the total number of BCTs are related to each other (r = 0.45 and r = 0.53 for experimental and
comparator groups, respectively), one can immediately see that there is considerable variability in
Figure 2. BCTs coded from published (white bars) and additional BCTs coded from unpublished (grey bars) materials for each
experimental (a) and comparator (b) group. Groups are ordered by number of behaviour change techniques coded from published
materials.
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reporting between studies. For example, experimental interventions that appear to deliver an iden-
tical number of BCTs based on published materials (e.g., ﬁve) turn out to vary widely when BCTs
identiﬁed in unpublished materials are also considered (i.e., ﬁve to forty-three BCTs). Consequently,
when ranking experimental and comparator groups based on their active content score (i.e., from
receiving the least to receiving the most BCTs), the ranking of groups looks quite diﬀerent when
only published or also unpublished materials are considered (see Figure 3(a and b); τb = 0.35 for
experimental, τb = 0.55 for comparators). Most groups were ranked substantially higher (above the
diagonal line) or lower (below the diagonal line) when unpublished materials were also considered.
Hence, there is considerable between-study variability in reporting quality, which aﬀects how much
active content experimental or comparator interventions from diﬀerent trials appear to deliver rela-
tive to each other.
Variability in active content reporting within trials
Another important characteristic of accurate reporting is that readers and systematic reviewers
should be able examine the additional value of an experimental intervention over its comparator.
Reporting quality for unique active content (i.e., the BCTs identiﬁed only for the comparator or the
experimental interventions within a trial) was nearly identical to the reporting quality for all BCTs
identiﬁed: only 29.4% (83/282) of the unique comparator BCTs and 40.6% (729/1794) of unique exper-
imental BCTs had been identiﬁed in published materials.
Figure 4a shows a scatterplot of the diﬀerence in the number of BCTs delivered to intervention
and comparator groups from the same trial, based on published descriptions (x-axis) and all available
materials (y-axis, r = .57). For 27/110 comparisons (25%; points on the diagonal line), the diﬀerence
was identical. For 30/110 (27%) comparisons, the diﬀerence between the experimental and compara-
tor intervention decreased (Mdn = 2, IQR = 9, range 1–27 BCTs) and for 53/110 (48%) comparisons, the
diﬀerence increased when unpublished materials in addition to published materials were considered
(Mdn = 4, IQR 8, range 1–22 BCTs). Accordingly, if you rank the trials based on the diﬀerence in the
number of experimental and comparator BCTs (e.g., from interventions that add only 1 BCT to
their comparator, to interventions that add 30 BCTs to their comparator), the order of the trials
changed considerably when unpublished materials were also considered (see Figure 4b; τb = 0.52).
Hence, these analyses show that BCT reporting quality also varies between groups from within the
same trial, which in turn aﬀects how superior – in terms of active content – interventions from
diﬀerent trials appear to be in relation to their comparator.
Figure 3. The ranking of (a) experimental and (b) comparator groups based on the number of BCTs identiﬁed in published versus
all intervention materials obtained. The size of the circle reﬂects the number of experimental or comparator groups contributing to
that data point.
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To examine whether these ﬁndings could in part be explained by method bias (i.e., checklists were
more often used for comparators and protocols more often for experimental interventions, which
could have produced diﬀerences in how comprehensive the information obtained was), we repeated
these analyses only for the 96 trials with well-described experimental and comparator groups.
However, results were virtually identical, suggesting that these primary results presented would be
similar also if the methods of data collection would have been identical for all study arms.
Factors associated with reporting quality and the retrieval of additional materials
Based on the binomial mixed-eﬀects logistic regression model, experimental interventions were
better reported (i.e., number of BCTs published / total number of BCTs identiﬁed) in the published
materials than comparator interventions (OR = 1.40, 95% CI [1.14–1.72], p = .001). Higher journal
impact factor appeared to be negatively associated with reporting quality (OR = 0.75, 95% CI
[0.55–1.03], p = .073). There was little evidence that other variables were associated with reporting
quality (all p≥ .20, see Table 3).
The results from the GEE logistic regression model (Table 4) indicated that the chances of obtain-
ing additional materials from study authors were higher for more recently published trials (OR = 1.10,
95%CI [1.03–1.17], p = .003) and trials published in behavioural journals (OR = 2.80, 95%CI [1.25–6.26],
p = .012). p-values for the other predictors were all ≥.25.
Discussion
In the current study, we managed to collect additional materials describing experimental and com-
parator interventions from a large sample of smoking cessation trials, and found that underreporting
Figure 4. The diﬀerence in the number of BCTs between experimental groups and their comparator based on published versus all
materials (a) and the ranking of these diﬀerences (b). The size of the circle reﬂects the number of experimental or comparator
groups contributing to that data point.
Table 3. Results from the binomial mixed-eﬀects logistic regression model predicting active content reporting quality.
Coeﬃcient Estimate SE z-val p-val
Intercept −0.922 1.019 −0.91 .365
Publication Year$ 0.023 0.023 0.99 .323
Journal Impact Factor# −0.289 0.161 −1.79 .073
Journal Type (1 = behavioural vs. 0 = medical) −0.341 0.264 −1.29 .197
Study Sample Size# 0.101 0.141 0.71 .475
Group (1 = Experimental vs. 0 = Comparator) 0.339 0.105 3.22 .001
Primary Delivery Mode (1 = interpersonal vs. 0 = written) −0.133 0.348 −0.38 .702
Notes: $ coded as ‘publication year – 1996’; # log transformed.
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of the presumed active content of behavioural smoking cessation interventions is common and –
importantly – varies considerably between diﬀerent trials as well as between diﬀerent groups from
within the same trial (experimental interventions seem to be better reported than comparators).
This is important as readers, systematic reviewers, practitioners, and policy makers require compar-
able descriptions of experimental and comparator interventions when interpreting (e.g., What
content did the intervention add to the comparator?), comparing (e.g., What content makes interven-
tion x more eﬀective than intervention y?), or generalising (e.g., What content does intervention x add
to the care provided in my clinic?) trial eﬀects. Comprehensive intervention descriptions are also an
important condition for the replication and implementation of interventions. When more than two-
thirds of the presumed active intervention content is missing from a published literature, and the
degree of omission varies so much between trials and between groups within trials – as observed
here – it undermines conﬁdence that the published literature can be used to conﬁdently answer
these questions.
On the up-side, and this also reﬂects one of the major strengths of this study, with a novel report-
ing tool (the checklist) and persistence of requests, we were able to contact almost all author teams of
the included trials published over a period of 20 years. For two-thirds of the trials we received valu-
able additional material describing the experimental and comparator interventions. We were less
likely to receive those from older studies and those published in medical journals, but as publication
year and journal type were only very weakly associated with reporting quality, we can be reasonably
conﬁdent that the results generalise to all the included trials.
The percentage of well-described interventions was an impressive 50% higher for the trials for
which authors sent us additional materials (see Table 1). This diﬀerence was not based on just a com-
parison with intervention descriptions in the primary trial paper (which is what most reporting studies
are using), but on comparisons with any published material we could ﬁnd describing the intervention
and trial (e.g., protocol papers, supplements, trial website, intervention development papers). Despite
the high author response rate, the active content of 29% (60/204) of the experimental and 23% (32/
142) of the comparator interventions (representing 37% [53/142] of trials), was scored as partly or
poorly described. Note that most of these authors did respond to our emails but were not able to
provide this information. Consequently, although they may report well on other trial and intervention
characteristics, the absence of comprehensive descriptions of presumed active content complicates
the interpretation, comparison, and generalisability of results in one-third of the included smoking
cessation trials; and presents an important barrier to their replication and implementation.
Our study builds on and extends a growing evidence base on intervention reporting. There are a
number of studies that show that reporting of intervention characteristics is suboptimal (Albarqouni
et al., 2018; Candy et al., 2018; di Ruﬀano et al., 2017; Glasziou et al., 2014; Glasziou, Meats, Heneghan,
& Shepperd, 2008; Hoﬀmann et al., 2013; Lohse et al., 2018; Mhizha-Murira, Drummond, Klein, &
dasNair, 2018; Warner, Kelly, Reidlinger, Hoﬀmann, & Campbell, 2017; Lorencatto et al., 2012). The
active content of interventions is evidently a crucial component of adequate trial reporting, yet
Table 4. GEE logistic regression modela examining predictors of whether authors provided additional intervention materials upon
request.
Coeﬃcient Estimate SE z-val p-val
Intercept −1.592 1.470 −1.08 .279
Publication Year$ 0.093 0.032 2.94 .003
Journal Impact Factor# 0.208 0.245 0.85 .395
Journal Type (1 = behavioural vs. 0 = medical) 1.029 0.411 2.50 .012
Study Sample Size# 0.053 0.229 0.23 .818
Group (1 = intervention vs. 0 = control) −0.152 0.134 −1.13 .257
Primary Delivery Mode (1 = interpersonal vs. 0 = written) 0.372 0.326 1.14 .254
Notes: aWe originally had planned to report a mixed-eﬀects logistic regression model with random trials eﬀects for these analyses.
Although that model produced very similar p-values as the GEE model (and identical conclusions), the mixed-eﬀects model gave
estimates that were unreasonably large and hard to interpret (since for many trials, additional materials were either provided for
none or all groups, leading to a very large variance component); $ coded as ‘publication year – 1996’; # log transformed.
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amongst all these studies we could ﬁnd only one that directly examined active content reporting in
behavioural trials (Lorencatto et al., 2012). This study revealed considerable underreporting of active
content (55.6%) in the primary trial papers, for the 28/152 (18.4%) experimental interventions for
which trial authors provided intervention manuals. Hence, this study provided an important signal
that reporting of active content in behavioural interventions may be suboptimal, but suﬀered
from methodological limitations that we were able to address in this study by collecting data on a
larger and more representative set of experimental and comparator interventions, examine all pub-
lished materials we could identify (not only the primary trial paper), explore variability in reporting
quality between trials and between groups from the same trials, and run pre-registered regression
models to explain reporting quality and author response rates.
The present study also has several potential limitations. First, we were unable to obtain unpub-
lished information for 36% of the intervention and comparator groups, mainly from older studies
and those published in medical journals. However, as we did not ﬁnd that publication year and
journal type were related to reporting quality, the high response rate combined with these meta-ana-
lyses provide reasonable conﬁdence that the results obtained generalise to the full sample of
smoking cessation trials. Secondly, we only examined smoking cessation interventions, which
could limit the generalisability of our ﬁndings to other behavioural interventions. It is worth
noting, however, that the smoking cessation literature captures a wide range of experimental and
comparator interventions used in the behavioural intervention literature. Also, in discussions with sys-
tematic reviewers who have attempted to code BCTs in experimental and comparator interventions,
an often-heard issue is the poor reporting of the interventions’ active content. Hence, the present
study has examined the scope, causes and possible implications of a well-recognised problem
amongst systematic reviewers of behavioural interventions; and has provided methods to tackle
this issue in future systematic reviews. Third, the active content for experimental interventions was
primarily identiﬁed through protocols and manuals that authors sent us, whereas the active
content of the comparator interventions was primarily identiﬁed from the checklist. This could
have resulted in method bias (e.g., the checklist provided a better insight in the comparator interven-
tion than the intervention protocols did for the experimental interventions), although we did not pre-
viously ﬁnd evidence for this (de Bruin et al., 2010). Finally, a general limitation for these type of
content analyses for behavioural interventions is that we do not know the relative eﬀectiveness of
each of the presumed active content components, and pragmatically chose to treat them all as equal.
The ﬁndings of this study have several implications. First, readers’ access to comprehensive
descriptions of the active content of experimental and comparator interventions has considerable
room for improvement. Authors should ensure that detailed descriptions are published of the inter-
ventions delivered to all treatment arms in their trial, and upload this information on publicly acces-
sible platforms such as the Open Science Framework. Our call for improved reporting of the potential
active components of behavioural interventions extends beyond the mere absence/presence of BCTs,
as it also seems important that authors report how they have applied the BCTs in their interventions
(e.g., in terms of BCT tailoring and other possible parameters of eﬀectiveness Kok et al., 2016; Peters,
de Bruin, & Crutzen, 2015). Research funders, journal editors, reviewers, and readers could play an
important role in stimulating this. Secondly, in an attempt to identify the most eﬀective ingredients
of behavioural interventions, many systematic reviews report meta-regression analyses in which they
associate eﬀect sizes with BCTs identiﬁed in published intervention descriptions. Even if intervention
reporting were unexpectedly to be twice as good in other literatures, this underreporting would still
raise concerns about potential biases, imprecision and confounding in these analyses. Hence, future
systematic reviews should aim to ensure that comprehensive descriptions for experimental and com-
parator interventions are available prior to conducting such analyses, for example, by contacting
study authors or restricting the analyses to well-described studies.
In conclusion, despite the availability of various reporting guidelines, published reports of the
active content of smoking cessation interventions are often incomplete. This study demonstrated
that active content reporting varies considerably between and within studies, which limits readers’
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ability to interpret, compare, and generalise the eﬀects reported by these trials. With considerable
investment, however, a substantial amount of information can be retrieved from study authors up
to 20 years back – although for approximately one-third of trials this was not possible. To tackle
incomplete reporting – and its consequences for science, policy, and practice – a concerted eﬀort
from multiple stakeholders is required. We would also caution that readers – be it scientists, prac-
titioners, or policy makers – keep in mind the issue of incomplete and variable reporting of the
active content experimental and especially comparator interventions when interpreting, comparing,
and generalising intervention eﬀects reported in smoking cessation trials.
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Appendix 1. Elaboration on the methods for assessing potential active content and
the data collection process (a reply to a Reviewer, added as Appendix upon
reviewer request)
In our methods, we make a distinction between practical intervention activities (which you would expect to read in an
intervention protocol or a smoking cessation guideline for practitioners) and behaviour change techniques (which are
given in a taxonomy and describe techniques that may modify behaviours or its determinants at a more abstract
level). This is similar to for example the concepts of practical applications and behaviour change methods in Intervention
Mapping (Eldredge et al., 2016. Planning Health Promotion Programmes: an Intervention Mapping Approach. Jossey-
Bass).
When we collect published materials and unpublished materials from study authors, we typically obtain documents
(e.g., articles, protocols) describing practical intervention activities. We then identify the potential active content of these
interventions by examining which of these activities target any of the four behaviours (quit, abstain, adherence, engage-
ment) and that qualify as a behaviour change technique. The approach is identical for the checklist: The checklist con-
tains a list of practical intervention activities that we identiﬁed frommultiple smoking cessation guidelines. The guideline
activities included in the checklist qualiﬁed as representing active content (i.e., qualify as behaviour change technique/s
and target one of the four behaviours of interest). Authors are asked to report which of these practical activities have
been delivered to their comparator groups, after which we link their responses to the BCTs in the v1 taxonomy (this
can be done with a syntax instead of with coders). So, both the intervention materials and the completed checklists
contain the same level of information (practical intervention activities). We use this information to identify the potential
active content of the smoking cessation support provided by identifying the activities that qualify as behaviour change
techniques targeting one of the four behaviours. Hence, there is no checklist versus BCTTv1, nor are there any BCTs in the
checklist, and the BCTs included in this study were those already deﬁned in the BCTTv1 taxonomy.
The reasons that the checklist items describe the practical intervention activities instead of the more abstract behav-
iour change technique deﬁnitions from the BCTTv1, are (a) this would require individual authors to make the translation
from practical intervention activities (i.e., what happened in the study) to BCTs – potentially introducing noise/error, and
(b) because we think recall is better when we ask for concrete, observable activities. For the same reason of recall, we ask
authors to report the activities that were delivered to the majority of their comparator group participants (i.e., the reg-
ularly recurring activities). We also asked authors to only complete the checklist if they felt conﬁdent about their
responses. In a previous study (de Bruin et al., 2009, 2010) we found that approximately 65% of the authors felt
conﬁdent in their ability to complete this checklist. In this study that was slightly lower (56%; note that we had
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established communication with approximately 95% of the study teams). Hence, a bit less than half of the teams
reported not feeling they had the information available to give meaningful responses.
We developed the checklist for assessing what the comparator groups were receiving. The reason for that is that
there is a major gap in the quality and quantity of materials that authors have available on what their experimental
group received versus their comparator group. Hence, solely relying on what the authors could send us in terms of inter-
vention materials (i.e., no method bias), would result in a major discrepancy in the amount and quality of information
available for experimental versus comparator interventions. The purpose of this checklist is to try to close that infor-
mation gap. In this way, we see the use of the checklist as an important strength of our methodology.
For developing the items for that checklist, we require access to the materials describing the interventions (i.e., to
identify the potential active practical activities to quit smoking). In this case, we used publicly available smoking cessation
guidelines from various countries (e.g., UK, USA). We extracted from these guidelines the practical intervention activities
that qualiﬁed as BCTs targeting any of the four behaviours. We then placed these ‘potentially active’ practical interven-
tion activities in the checklist. We discussed this checklist with smoking cessation experts (professionals, researchers, and
clients) to ensure that it was clear, comprehensive, and accurate. It is important to note that this checklist is not all-
encompassing: it should include a good range of the most commonly provided activities in smoking cessation pro-
grammes in treatment-as-usual contexts. But it is unlikely to contain many of the potential active ingredients of the
experimental smoking cessation interventions, as this would require us to ﬁrst obtain all the intervention materials; iden-
tifying in these materials the potential active ingredients; including those potentially active elements as items in the
checklist, and then sending that checklist back to trial authors to ask them what their intervention group received.
Besides that this would create considerable delay in the project, we could also anticipate low response rates and
annoyed authors as they had already provided us with all the materials necessary to infer what was happening in
their interventions.
In our previous checklist study (de Bruin et al., 2009, 2010) we observed a high internal consistency reliability of the
checklist and good predictive validity for behaviour and clinical outcomes. Such high reliability is unlikely if author’s
responses were sketchy. Also, in our current smoking cessation study, the internal consistency reliability of the checklist
is high (Cronbach’s alpha .92) and (sneak preview) in a manuscript under review, we again see good predictive validity of
the checklist responses for smoking cessation rates in the comparator groups and in eﬀect sizes. In other words, the
checklist has been carefully and systematically developed and examined both previously and in this study, and the ana-
lyses all support that these checklist data are reliable and valid.
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